Outset Medical, Inc. (OM)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$3.59+0.56%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · OM
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Elevated risk of a next-quarter earnings miss: this name is on a run of consecutive earnings misses and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
OM — General Counsel transition
Dated 2026-08-28
General Counsel — John Brottem: The General Counsel is resigning to pursue other opportunities without any dispute, representing a standard executive departure.
Why it matters: Keeping this margin is important for making money in the long run. It matches what management wants.
Supportive ifNon-GAAP gross margin reported above 40%.
Worry ifNon-GAAP gross margin reported below 40%.
Why it matters: Keeping this margin is important for making money. It shows how well the company runs.
Supportive ifGross margin reported in the low to mid-40% range confirms strong cost management.
Worry ifGross margin is below 40%. This shows possible problems with controlling costs.
Why it matters: Changes in leaders can change R&D focus and company plans.
Worry ifAppointment of a new executive with a strong background in R&D.
Less concerning ifNo new leaders or ongoing problems with leadership are seen.
Why it matters: This deal could bring in more customers. It may also help show future orders.
Supportive ifNew installations or orders are coming under the HCA agreement.
Worry ifNo updates or delays in the HCA fleet refresh agreement.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$321 on $10,000 · ±3.2% | How much price usually moves either way. |
| Bad day | $884 loss on $10,000 · 8.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,001 loss on $10,000 · 80.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Confirming or revising the revenue guidance shows how well the company is tracking its growth goals.
Watch forOutset confirms its 2026 revenue guidance of $125 million to $130 million.
Also watch forOutset revises its 2026 revenue guidance down below $125 million.
Why it matters: Meeting or exceeding this revenue shows the company is on track for its 2026 guidance.
Supportive ifQ3 revenue reported at or above $31.6 million.
Worry ifQ3 revenue reported below $31.6 million.